Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Arq. bras. neurocir ; 39(3): 228-231, 15/09/2020.
Article in English | LILACS | ID: biblio-1362413

ABSTRACT

Colorectal cancer is one of the most common oncological diseases. Chemotherapy is usually recommended as an adjuvant treatment for stage-II, -III, and -IV tumors. Approximately 10% of the patients develop neuropathic pain after chemotherapy, and they may remain refractory despite the administration of drugs that are commonly used to treat neuropathic pain. Spinal cord stimulation is a good treatment option for neuropathic pain of the lower limbs, and it should be trialed in patients with chemotherapy-induced peripheral neuropathy. We report the case of a patient with oxaliplatin-induced neuropathy and neuropathic pain refractory to oral medication who was successfully treated by spinal cord stimulation.


Subject(s)
Humans , Female , Middle Aged , Polyneuropathies/surgery , Polyneuropathies/diagnosis , Polyneuropathies/chemically induced , Spinal Cord Stimulation/methods , Colorectal Neoplasms, Hereditary Nonpolyposis/epidemiology , Chemotherapy, Adjuvant , Peripheral Nervous System Diseases/therapy , Cancer Pain
2.
Gac. méd. Méx ; 155(4): 428-435, jul.-ago. 2019. graf
Article in English, Spanish | LILACS | ID: biblio-1286529

ABSTRACT

Resumen El dolor neuropático es una entidad que provoca discapacidad al paciente y su diagnóstico y tratamiento es un reto para los médicos. En un porcentaje importante de pacientes afectados, el dolor neuropático se presenta circunscrito a un dermatoma o a una región concreta del cuerpo, denominándose en ese caso dolor neuropático localizado. No existen guías clínicas mexicanas que postulen recomendaciones para el diagnóstico y tratamiento del dolor neuropático localizado en nuestra población. En este artículo se exponen las recomendaciones de un consenso multidisciplinario realizado con especialistas de distintas áreas implicadas en el diagnóstico y tratamiento de este tipo de pacientes.


Abstract Neuropathic pain is an entity that causes patient disability and its diagnosis and treatment is a challenge for physicians. In a significant percentage of patients with neuropathic pain, it is restricted to one dermatome or to a particular region of the body; in this case, it is referred to as localized neuropathic pain. There are no Mexican clinical guidelines proposing recommendations for the diagnosis and treatment of localized neuropathic pain in our population. This article presents the recommendations of a multidisciplinary consensus of specialists from different areas involved in the diagnosis and treatment of this type of patients.


Subject(s)
Humans , Peripheral Nervous System Diseases/diagnosis , Neuralgia/diagnosis , Peripheral Nervous System Diseases/therapy , Mexico , Neuralgia/therapy
3.
Rev. Assoc. Med. Bras. (1992) ; 65(2): 281-286, Feb. 2019. tab, graf
Article in English | LILACS | ID: biblio-990318

ABSTRACT

SUMMARY INTRODUCTION: Peripheral neuropathy is a disorder that affects the cell body, axon or myelin of motor or peripheral sensory neurons and occurs in 60-100% of patients who are submitted to dialysis due to chronic kidney disease. Uremic neuropathy is attributed to the accumulation of organic waste, evident in patients with reduced glomerular filtration rate. Objectives: This review aims to make clinical characteristics of uremic neuropathy evident enabling early diagnosis and treatment. Methods: This is a literature review of articles published on PubMed over the last 10 years using "Uremic Neuropathy" as "Title/Abstract". Results: A total of nine articles that met the inclusion criteria were included. UN is a distal symmetric sensorimotor polyneuropathy that occurs due to the accumulation of uremic toxins associated with an oxidative stress-related free radical activity. Hyperkalemia is thought to play an important role in its pathophysiology. Diagnosis depends on nerve conduction studies, and treatment includes dialysis or renal transplant. Conclusion: Clinical presentations of UN are broad and non-specific; nonetheless, it is important to detect early changes in order to avoid its progression. The earlier UN is diagnosed and treated, the more successful are the clinical outcomes.


RESUMO INTRODUÇÃO: A neuropatia periférica (NU) é um distúrbio que afeta o corpo celular, o axônio ou a mielina do motor ou neurônios sensoriais periféricos e ocorre em 60%-100% dos pacientes que são submetidos à diálise por doença renal crônica. A neuropatia urêmica é atribuída à acumulação de resíduos orgânicos, evidente em pacientes com taxa de filtração glomerular reduzida. Objetivo: O objetivo desta revisão é fazer com que as características clínicas da neuropatia urêmica sejam evidenciadas, permitindo o diagnóstico e tratamento precoce. Método: Esta é uma revisão da literatura de artigos publicados no PubMed nos últimos dez anos usando "Neuropatia Urêmica" como "Título/Resumo". Resultados: No total, foram incluídos nove artigos que atendem aos critérios de inclusão. A NU é uma polineuropatia sensório-motora simétrica distal que ocorre devido ao acúmulo de toxinas urêmicas associadas à atividade de radicais livres relacionados ao estresse oxidativo. A hipercalemia tem um papel importante na sua fisiopatologia. O diagnóstico depende de estudos de condução nervosa e o tratamento inclui diálise ou transplante renal. Conclusão: As apresentações clínicas das NU são amplas e não específicas; no entanto, é importante detectar mudanças iniciais para evitar sua progressão. Quanto mais precoce for a detecção e tratamento da NU, melhor será o resultado clínico.


Subject(s)
Humans , Uremia/diagnosis , Uremia/physiopathology , Uremia/therapy , Peripheral Nervous System Diseases/diagnosis , Peripheral Nervous System Diseases/physiopathology , Peripheral Nervous System Diseases/therapy , Renal Dialysis , Kidney Transplantation
4.
Int. j. morphol ; 31(3): 1124-1129, set. 2013. ilus
Article in Spanish | LILACS | ID: lil-695011

ABSTRACT

El ultrasonido continuo fundamenta su efectividad en la energía térmica que genera, favoreciendo la reparación nerviosa. Es por esto que surge la interrogante de que si al aplicar diferentes intensidades de ultrasonido continuo sobre el nervio espinal lesionado, la respuesta reparativa será igual o distinta. Para ello se utilizaron 12 ratas de sexo masculino a las que se les aisló quirúrgicamente el nervio isquiático, el cual fue pinzado durante 45 segundos con una fuerza constante de 40N. La compresión se realizó a 10mm sobre la bifurcación, luego se desinfectó y suturó. Inmediatamente después de la operación las ratas fueron agrupadas de a 3: A) control sano, B) control lesionado, C) aplicación de ultrasonido terapéutico de 0,5w/cm2 y D) aplicación de ultrasonido terapéutico de 1w/cm2. El grupo A se utilizó como control sano y no recibió irradiación. Las ratas del grupo B fueron lesionadas y no recibieron irradiación y las del grupo C y D fueron lesionadas e irradiadas transcutáneamente en la región correspondiente al recorrido del nervio isquiático utilizando intensidades de 0,5w/cm2 y 1w/cm2, 3 MHZ de frecuencia, un cabezal de 0,5cm2, durante 1 minuto y 10 días consecutivos. 28 días post operatorio se extrajeron los nervios isquiáticos y fueron sometidos a técnicas de tinción de H-E y Van Gieson. Se realizó el diagnóstico histopatológico y la morfometría: se midió el Grosor del Perineuro, Perímetro del núcleo del Schwannocito, Perímetro del Axón Mielínicoy Perímetro de la Mielina. Los resultados revelan que el ultrasonido continuo es efectivo en la reparación del nervio espinal, siéndolo más con 1w/cm2 que con 0,5w/cm2.


The continuous ultrasound bases its efficiency on the heat energy it generates, favoring the nervous repair. Therefore, the question arises whether the reparative response will be equal or different under varying intensities of continuous ultrasound application on the disabled spinal nerve. For the study we used 12 male rats; the ischiatic nerve was surgically isolated and compressed during 45 seconds with a constant force of 40N. The compression was realized at 10 mm on the bifurcation, and was subsequently disinfected and sutured. Immediately following the operation the rats were separated in groups of 3: A) Healthy control, B) Injured control, C) Application of therapeutic ultrasound of 0.5 w/cm2 and D) Application of therapeutic ultrasound of 1 w/cm2. Group A was used as healthy control and did not receive irradiation. The rats in group B were injured and did not receive irradiation and those of groups C and D were injured and were transcutaneously irradiated in the area corresponding to the ischiatic nerve using intensities of 0.5 w/cm2 and 1 w/cm2, 3 MHZ of frequency. We used a compress of 0.5 cm2, during 1 minute and for 10 consecutive days. 28 days post operative ischiatic nerves were removed and submitted to technologies of H.E and VG stain. Histopathological and morphometrical diagnosis was realized: Thickness of the Perineurium, schwannocyte perimeter, Myelin Axon and Myelin perimeters were measured. The results revealed that the continuous ultrasound is effective in the repair of the spinal nerve, more so with 1 w/cm2 than with 0.5 w/cm 2.


Subject(s)
Male , Animals , Rats , Peripheral Nervous System Diseases/therapy , Sciatic Nerve/injuries , Ultrasonic Therapy/methods , Spinal Nerves/injuries , Rats, Sprague-Dawley , Nerve Compression Syndromes/complications
5.
In. Salamano Tessore, Ronald L; Scaramelli Giordan, Alejandro; Oehninger Gatti, Carlos L. Diagnóstico y tratamiento en neurología. Montevideo, Dedos, oct.2012. p.447-453.
Monography in Spanish | LILACS | ID: lil-759867
6.
Rev. bras. anestesiol ; 61(5): 649-658, set.-out. 2011. tab
Article in Portuguese | LILACS | ID: lil-600957

ABSTRACT

JUSTIFICATIVA E OBJETIVOS: As neuropatias dolorosas são frequentes e muitas vezes de difícil tratamento. O objetivo deste texto foi fazer uma revisão para facilitar o diagnóstico e o alívio da dor. CONTEÚDO: Descreveram-se a classificação, as causas, o tipo de fibra envolvida, as manifestações, o diagnóstico, os exames complementares, os questionários usados para diagnóstico e os tratamentos. CONCLUSÕES: O tema é bastante amplo e envolve diversas causas e tratamentos que muitas vezes devem ser associados para o controle adequado da dor.


BACKGROUND AND OBJECTIVES: Painful neuropathies are common and often difficult to treat. The objective of this report was to review the subject to facilitate diagnosis and pain relief. CONTENTS: The classification, causes, type of fibers involved, manifestations, diagnosis, adjuvant tests, questionnaires used in the diagnosis, and treatment are described. CONCLUSIONS: The subject is very broad and involves several causes and treatments that often should be combined to obtain adequate pain control.


JUSTIFICATIVA Y OBJETIVOS: Las neuropatías dolorosas son comunes y muchas veces, de difícil tratamiento. El objetivo de este texto fue hacer una revisión para facilitar el diagnóstico y el alivio del dolor. CONTENIDO: Fueron descritas la clasificación, las causas, el tipo de fibra involucrada, las manifestaciones, el diagnóstico, los exámenes complementarios, los cuestionarios usados para el diagnóstico y los tratamientos. CONCLUSIONES: Eltema es muy amplio y envuelve diversas causas y tratamientos que muchas veces deben ser asociados con el control adecuado del dolor.


Subject(s)
Diagnosis, Differential , Peripheral Nervous System Diseases/classification , Peripheral Nervous System Diseases/diagnosis , Peripheral Nervous System Diseases/therapy , Pain Measurement
7.
DARU-Journal of Faculty of Pharmacy Tehran University of Medical Sciences. 2011; 19 (1): 65-70
in English | IMEMR | ID: emr-106480

ABSTRACT

Diabetic neuropathy is the most common diabetic complication that often is accompanied by significant morbidity, mortality and economic burden. The purpose of this study was evaluation of effect of Semelil [ANGIPARS[TM]], a new herbal drug for treatment of diabetic foot ulcers or diabetic peripheral neuropathy. In this double blind clinical trial, 49 type 2 diabetes patients with different degrees of neuropathy were evaluated in two groups [ANGIPARS[TM] and placebo groups]. All patients were assessed at the start and 12 weeks after treatment, with laboratory tests, United Kingdom screening test, Michigan neuropathy screening score, Michigan diabetic neuropathy score, vibration perception thresholds, nerve conduction study, monofilament test and visual analog scale. Michigan diabetic neuropathy score was decreased notably in ANGIPARS[TM] group. In the nerve conduction study, appropriate meaningful changes were observed in the distal latency and amplitude in the motor ulnar nerve in ANGIPARS[TM] group. The results showed limited evidence of efficacy of ANGIPARS[TM] in diabetic neuropathy treatment and more studies with a larger sample size and longer duration are required


Subject(s)
Humans , Male , Female , Diabetic Neuropathies/drug therapy , Peripheral Nervous System Diseases/therapy , Double-Blind Method , Placebos , Diabetes Complications , Diabetic Foot/therapy , Diabetes Mellitus, Type 2
8.
Egyptian Journal of Neurology, Psychiatry and Neurosurgery [The]. 2008; 45 (2): 313-319
in English | IMEMR | ID: emr-86315

ABSTRACT

Patients with long standing diabetic peripheral Neuropathy suffers marked affection of lower limb proprioception and often develop balance problems that can significantly increase fall risk. The purpose of this study was to determine whether the application of Monochromatic infrared photo energy [MIRE] to the lower extremities of patients with diabetic peripheral Neuropathy would improve balance and gait patterns. The study conducted on 40 diabetic patients with peripheral neuropathy divided equally into two groups [20 patients each]. Group I received exercise program only, Group II received in addition to exercise program 30 minutes Monochromatic Infrared Photo Energy [MIRE] three times a week for one month. Tandem walk [TW] test was used to assess mean step width, speed and end sway pre and post therapy in both groups of patients. Both groups were selected to have identical clinical characteristics, mean of age, duration of both diabetes and peripheral Neuropathy, Blood sugar control. Highly statistical significant difference [p<0.0001] between the two groups regarding speed post therapy implicating the beneficial effect of Monochromatic infrared photo energy [MIRE] on balance parameters. As deducted from the observed data as well as from the reviewed literature we could recommend that the application of 12 photo therapy sessions induced improvement in balance and consequently decrease the incidence of falls in diabetic peripheral neuropathy


Subject(s)
Humans , Male , Female , Peripheral Nervous System Diseases/therapy , Infrared Rays , Diabetes Mellitus , Postural Balance , Treatment Outcome , Diabetes Complications
9.
Dolor ; 16(48): 24-28, nov. 2007.
Article in Spanish | LILACS | ID: lil-677754

ABSTRACT

El síndrome de dolor regional complejo tipo II o causalgia es un cuadro que se presenta con dolor intenso y síntomas autonómicos importantes, que alteran la calidad de vida de los pacientes. Sus mecanismos fisiopatológicos todavía están en discusión y la evidencia disponible para su manejo aún es escasa. Actualmente, la tendencia es hacia un manejo interdisciplinario que abarque terapias psicológicas, de rehabilitación, en conjunto con un correcto manejo del dolor.


Type II complex regional pain syndrome causes accute pain and autonomous symptoms that alter the patient's quality of life. Discussion with respect to the syndrome physiopathologic mechanisms is still open and available evidence is scarce. The present trend is the multidisciplinary approach with teams using psychological, rehabilitation and pain management therapies.


Subject(s)
Humans , Male , Female , Causalgia/drug therapy , Causalgia/rehabilitation , Peripheral Nervous System Diseases/drug therapy , Peripheral Nervous System Diseases/rehabilitation , Peripheral Nervous System Diseases/therapy , Administration, Topical , Activities of Daily Living/psychology , Analgesics, Opioid/therapeutic use , Anticonvulsants/therapeutic use , Antidepressive Agents/therapeutic use , Adrenal Cortex Hormones/therapeutic use , Reflex Sympathetic Dystrophy/diagnosis , Sympathectomy/methods , Exercise Therapy/methods
10.
Libyan Journal of Infectious Diseases [The]. 2007; 1 (2): 63-75
in English | IMEMR | ID: emr-84039

ABSTRACT

More than half of HIV-infected persons develop symptomatic neurological disease. The nervous system is extensively involved with no part of the neuraxis being immune from the virus. HIV-associated neuropathies have become the most frequent neurological disorder associated with HIV infection. The most common forms of HIV-associated neuropathies are the distal sensory polyneuropathy [DSP] and antiretroviral toxic neuropathy. Other forms include acute or chronic inflammatory polyneuropathies. Mononeuritis multiplex or radiculopathies may occur in late stages and are mostly associated with opportunistic infections. Furthermore, HIV-related muscle involvement is an uncommon but important complication. This may be due to polymyositis, HIV-associated wasting syndrome or may be aggravated by drugs. The aim of this review is to evaluate the available data on clinical manifestations, pathogenesis, investigations and the therapeutic implication for peripheral nervous system [PNS] neuropathies complications of HIV/AIDS. This review summarises those issues that are likely to confront clinicians, including those who do not routinely treat people infected with HIV


Subject(s)
Humans , Polyneuropathies/etiology , Polyneuropathies/virology , Peripheral Nervous System Diseases/virology , Myositis/virology , Peripheral Nervous System Diseases/therapy , Peripheral Nervous System Diseases/diagnosis , Peripheral Nervous System Diseases/pathology , Polyradiculopathy/pathology , Early Diagnosis , Acquired Immunodeficiency Syndrome
11.
Arq. neuropsiquiatr ; 62(3B): 895-898, set. 2004. ilus
Article in English | LILACS | ID: lil-384150

ABSTRACT

O presente artigo relata caso clínico incomum de neuropatia proximal de membro inferior, demonstra eletrofisiologicamente o comprometimento neural e revisa a literatura médica sobre o assunto. O teste neurofisiológico que demonstrou a patologia foi o potencial evocado somato-sensitivo (PES) segmentar do ramo cutâneo lateral do nervo ílio-hipogástrico. Ele revelou potenciais corticais bem definidos e replicáveis à estimulação do membro inferior assintomático, mas falhou em produzir respostas corticais do membro inferior sintomático. Na revisão da literatura não foi encontrado nenhum relato anterior de diagnóstico dessa patologia por PES segmentar. Conclui-se que é importante ter em mente ao avaliar pacientes com queixas de dor e disestesia na base dos membros inferiores que o acometimento de pequenos ramos cutâneos, como o cutâneo lateral do ílio-hipogástrico, pode ter confirmação eletrofisiológica da patologia por testes neurofisiológicos como o potencial evocado somato-sensitivo segmentar.


Subject(s)
Adult , Female , Humans , Evoked Potentials, Somatosensory , Hypogastric Plexus , Ileum/innervation , Paresthesia/diagnosis , Peripheral Nervous System Diseases/diagnosis , Electrophysiology , Nerve Block , Peripheral Nervous System Diseases/therapy
12.
An. paul. med. cir ; 128(2): 40-46, abr.-jun. 2001. ilus, tab
Article in Portuguese | LILACS | ID: lil-319587

ABSTRACT

A neuropatia vasculítica é a mais comum das neuropatias parenquimatosas. As formas restritas ao sistema nervoso periférico (SNP) e as secundárias a doenças sistêmicas têm a mesma expressäo clínica e imunopatológica. Assim, podem ser consideradas como polos de expressäo da mesma doença. O diagnóstico deve ser considerado diante de uma neuropatia assimétrica dolorosa e confirmado por biópsia do nervo periférico. A introduçäo precoce de um tratamento imuno-supressor potente e prolongado reduz significativamente os riscos de sequelas incapacitantes. Säo relatados os aspectos clínicos, anatomopatológicos e as opções terapêuticas adotadas em 15 pacientes com neuropatia vasculítica, 2 com forma primária e 13 com afecçäo secundária do SNP. A resposta ao tratamento foi favorável, em grau variável e relacionado ao tempo de evoluçäo e às condições iniciais do paciente


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Peripheral Nervous System Diseases/diagnosis , Immunosuppressive Agents , Peripheral Nervous System Diseases/therapy
13.
Rev. cuba. enferm ; 15(2): 114-8, mayo-ago. 1999. tab
Article in Spanish | LILACS, BDENF | ID: lil-271034

ABSTRACT

Se analizó un ensayo clínico sobre el efecto de la ozonoterapia en pacientes con neuropatía periférica de febrero a mayo de 1996 en el Centro Provincial de Retinosis Pigmentaria de Camagüey y a una muestra de 40 pacientes, con predominio del sexo femenino, el grupo de edades comprendido entre 36 y 45 años; los más afectados fueron los profesionales en 12 pacientes, seguido de los obreros con 7. Los signos y síntomas más relevantes fueron las mialgias con 34 casos, calambres con 25 casos, cefaleas con 22, pérdida del equilibrio 2 casos, decaimiento 20 casos. La vía más usada para el tratamiento fue la rectal y se observó una evolución satisfactoria en 34 pacientes, lo que demuestra la efectividad de la ozonoterapia en pacientes con neuropatía periférica


Subject(s)
Ozone/therapeutic use , Disease Outbreaks , Peripheral Nervous System Diseases/epidemiology , Peripheral Nervous System Diseases/therapy
14.
Rev. bras. ortop ; 33(1): 76-8, jan. 1998. ilus
Article in Portuguese | LILACS | ID: lil-209402

ABSTRACT

A posiçäo adotada pelo paciente durante o ato operatório é de grande importância, principalmente em se tratando de cirurgias de longa duraçäo e que necessitam de anestesia geral. Os autores relatam um caso raro de lesäo incompleta do plexo braquial em um paciente submetido a uma artroplastia total do quadril (ATQ) devido ao posicionamento inadequado do membro superior durante a cirurgia.


Subject(s)
Humans , Male , Adult , Arthroplasty, Replacement, Hip/adverse effects , Brachial Plexus/injuries , Peripheral Nervous System Diseases/etiology , Peripheral Nervous System Diseases/therapy , Intraoperative Period , Posture
15.
Arq. neuropsiquiatr ; 55(1): 130-5, mar. 1997. ilus
Article in Portuguese | LILACS | ID: lil-194715

ABSTRACT

Relata-se o caso de paciente de 25 anos com ferimento porarma de fogo na articulacao coxofemural esquerda que desenvolveu, entre outros sinais de intoxicacao plumbica, polineuropatia periferica axonal predominantemente motora. Tratado inicialmente com corticosteroides em doses imunossupressoras obteve melhora, mas apresentava recidiva a cada tentativa de retirada da medicacao. Demonstrados laboratorialmente niveis sericos toxicos de chumbo, foi submetido a quelacao com EDTA e a retirada cirurgica do projetil, com boa recuperacao dapolineuropatia, sem necessidade ulterior de corticosteroides. Enfatiza-se: 1) o possivel papel do sistema imune na fisiopatogenia da intoxicacao por chumbo, podendo ser um dos motivos das diferentes apresentacoes clinicas das neuropatias plumbicas na infancia e no adulto; 2) a importancia da retirada do material plumbeo quando alojado em articulacoes.


Subject(s)
Humans , Male , Adult , Lead Poisoning/immunology , Peripheral Nervous System Diseases/immunology , Wounds, Gunshot/immunology , Femur/injuries , Glucocorticoids/administration & dosage , Joints/injuries , Lead Poisoning/complications , Lead Poisoning/physiopathology , Lead Poisoning/therapy , Lead/blood , Peripheral Nervous System Diseases/etiology , Peripheral Nervous System Diseases/physiopathology , Peripheral Nervous System Diseases/therapy , Prednisone/administration & dosage , Wounds, Gunshot/complications , Wounds, Gunshot/physiopathology , Wounds, Gunshot/therapy
16.
Rev. cuba. oftalmol ; 7(1/2): 39-51, ene.-dic. 1994. tab
Article in Spanish | LILACS | ID: lil-158510

ABSTRACT

Se realizó un ensayo clínico terapéutico multicéntrico en Ciudad de La Habana, en 576 pacientes afectados de neuropatía epidémica forma óptica, en el período comprendido entre abril de 1993 y febrero de 1994. Se emplearon 11 esquemas de tratamiento, distribuidos aleatoriamente entre los hospitales participantes. Los grupos de tratamiento incluidos fueron : dexametasona, metilprednisolona, hidroxicobalamina+metionina+tiosulfato de sodio, vitaminas, magnetoterapia, ozonoterapia, oxigenación hiperbárica, electroforesis endonasal con vitamina B1, factor de trasnferencia, interferón (INF) alfa natural e interferón alfa 2b recombinante. A todos los pacientes del estudio se les administró vitaminas de base y se consideró a aquéllos tratados con vitaminas sólo como grupo control. La evaluación de los casos se realizó a los 21 días (alta hospitalaria), al mes, 3 y 6 meses, respectivamente. El tratamiento con ozono reflejó diferencias estadísticamente significativas (p<0,05) (en cada uno de los cortes evaluativos efectuados) en cuanto a mejoría y recuperación de los casos tratados con ese proceder. En el resto de los esquemas terapéuticos empleados no se encuentran diferencias significativas. Se evidenció la utilización de las vitaminas


Subject(s)
Humans , Peripheral Nervous System Diseases/drug therapy , Peripheral Nervous System Diseases/therapy , Optic Neuritis/drug therapy , Optic Neuritis/therapy , Ozone/therapeutic use , Disease Outbreaks , Peripheral Nervous System Diseases/epidemiology
18.
Rev. bras. neurol ; 29(5): 140-6, out. 1993. tab
Article in Portuguese | LILACS | ID: lil-130113

ABSTRACT

Os autores descrevem as polineuropatias (PN) nas gamapatias monoclonais de etiologia indeterminada (GME1). Referem-se ao quadro clínico, eletroneuromiográfico e aos achados histológicos nas PN das GMEI por IgM e IgG. Citam também os vários aspectos da terapêutica e da evoluçäo destas afecçöes. Relatam 14 casos, por eles estudados, nove por IgG e cinco por IgM, sendo nove mulheres e cinco homens. A idade média do início foi de 69 anos. Dois enfermos apresentavam tremor associado à PN. Em quase todos a VHS estava elevada, assim como as proteínas no LCR. Nos estudos eletrofisiológicos predominaram alteraçöes axonais na PN por IgG e distúrbios desmielizantes nas PN por IgM. A prednisona foi utilizada em cinco pacientes com PN por IgG e em três enfermos com PN por IgM. O uso deste fármaco näo autorizou dizer se seria ou näo o medicamento de escolha neste tipo de PN


Subject(s)
Humans , Male , Female , Middle Aged , Monoclonal Gammopathy of Undetermined Significance/complications , Peripheral Nerves/physiopathology , Peripheral Nervous System Diseases/etiology , Blood Protein Electrophoresis , Electromyography , Hemoglobins/analysis , Immunoglobulin G/analysis , Immunoglobulin M/analysis , Monoclonal Gammopathy of Undetermined Significance/diagnosis , Paraproteinemias/complications , Paraproteinemias/diagnosis , Peripheral Nervous System Diseases/pathology , Peripheral Nervous System Diseases/therapy
19.
Rev. paul. med ; 108(3): 142-4, maio-jun. 1990.
Article in Portuguese | LILACS | ID: lil-89183

ABSTRACT

O autor um caso de neuropatia periférica por inalaçäo voluntária crônica de benzina (n-hexano). A literatura mostra que se trata de complicaçäo relativamente rara, embora já descrita. O quadro tende a apresentar bom prognóstico, com remissäo completa, se o paciente conseguir manter-se abstinente


Subject(s)
Humans , Adult , Male , Peripheral Nervous System Diseases/etiology , Substance-Related Disorders , Hexanes , Psychotherapy , Physical Therapy Modalities , Peripheral Nervous System Diseases/therapy
SELECTION OF CITATIONS
SEARCH DETAIL